Mortality associated with congenital heart disease (CHD) accounts for up to 50% of pediatric deaths with over 48% of CHD mortality occurring in children less than 1 year of age. Post-operative infections contribute significantly to this mortalty with a recent study indicating a mortality rate of nearly 25% associated with post- operative infections. Nearly all children with CHD require surgical correction of their lesions necessitating the use of cardiopulmonary bypass (CPB). However, CPB stimulates the immune system to produce pro- inflammatory cytokines that are counteracted by a compensatory anti-inflammatory response generated by the immune system. In some children, this compensatory anti-inflammatory response remains prolonged, leading to an """"""""immunoparalyzed"""""""" state in which the pediatric patients are no longer able to fend off pathogens resulting in post-operative infections. Importantly, immunoparalysis can be revered in critically ill children by treating them with granulocyte macrophage colony-stimulating factor (GM-CSF). Even though immunoparalysis is associated with the dysregulation of immune function and the devastating consequences of post-operative infections, it remains a challenge for clinicians to identify those children who are immunoparalyzed and may benefit from GM-CSF to prevent post-operative infections. One major reason for the limited identification of children with immunoparalysis is the lack of validated immunomonitoring platforms that can allow real-time determinations of immunoparalysis. Two current methods exist to detect immunoparalysis: whole blood stimulation assay, which involves measurements of the capacity of peripheral blood leukocytes to produce inflammatory cytokines following pathogen stimulation using ELISA, and flow cytometry for enumeration of peripheral blood monocytes expressing HLA-DR receptors. The whole blood stimulation assay is time-consuming and can only provide the clinician with a determination of immunoparalysis in 72 hrs at the earliest. Flow cytometry for enumeration of peripheral blood monocytes expressing HLA-DR receptors can provide fast results;however it does not reflect the functional status of monocytes. Further, current protocols for isolation and functional testing of key leukocyte subpopulations (such as monocytes) require blood volumes that make such testing dangerous in small children. Thus, to understand the impact of immunoparalysis on outcomes for children following CPB as well as to identify functional status of key leukocyte subpopulations that are dysregulated in children who are immunoparalyzed, there exists a significant need for a real-time, functional immunophenotyping method that can achieve accurate, multiplexed functional cellular characterization of subpopulations of immune cells using only minute amounts of patient blood. To address this need, our central objective of this research is to develop an integrated microfluidic immunosensing platform for efficient isolation, enrichment, enumeration, and sensitive multiplexed functional immunophenotyping of subpopulations of immune cells from blood specimens. To extend our research to make clinical impact, we propose to implement our microfluidic immunomonitoring technology to further determine the incidence and impact of immunosuppression in critically ill children and its functional connection to post-operative infections.
The Specific Aims of this collaborative R01 research thus are:
(Aim 1) To develop and validate an integrated microfluidic immunophenotyping assay (MIPA) device for rapid, accurate, and sensitive parallel detection of multiple cytokines secreted by immune cells;
(Aim 2) To develop and validate an integrated MIPA device for efficient isolation, enrichment, enumeration, and multiplexed functional immunophenotyping of subpopulations of immune cells from blood specimens;
(Aim 3) To utilize the MIPA device to identify immunoparalyzed pediatric patients following CPB and determine its predictive power for post-operative infections.

Public Health Relevance

The use of cardiopulmonary bypass to correct congenital heart disease in pediatric patients initiates a systemic inflammatory response that can lead to dysfunction of the immune system resulting in an increased risk for post-operative infection and ultimately patient death. Currently, physicians do not monitor the function of the immune system in pediatric patients, even though medications may be used to reverse the immune dysfunction, which is largely due to the current lack of standardized immunophenotyping tools. Our proposed research is set to address specifically this critical issue, by developing a highly integrated, automated microfluidic immunomonitoring technology to provide real-time functional immune status for children who have undergone cardiopulmonary bypass with the added benefit of requiring only minute amounts of patient blood.

National Institute of Health (NIH)
National Heart, Lung, and Blood Institute (NHLBI)
Research Project (R01)
Project #
Application #
Study Section
Special Emphasis Panel (ZRG1)
Program Officer
Lee, Albert
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Michigan Ann Arbor
Engineering (All Types)
Biomed Engr/Col Engr/Engr Sta
Ann Arbor
United States
Zip Code
Cornell, Timothy T; Selewski, David T; Alten, Jeffrey A et al. (2018) Acute kidney injury after out of hospital pediatric cardiac arrest. Resuscitation 131:63-68
Li, Zida; Wang, Yize; Xue, Xufeng et al. (2018) Carbon Nanotube Strain Sensor Based Hemoretractometer for Blood Coagulation Testing. ACS Sens 3:670-676
Song, Yujing; Chen, Pengyu; Chung, Meng Ting et al. (2017) AC Electroosmosis-Enhanced Nanoplasmofluidic Detection of Ultralow-Concentration Cytokine. Nano Lett 17:2374-2380
Zhao, Gang; Fu, Jianping (2017) Microfluidics for cryopreservation. Biotechnol Adv 35:323-336
Kotnala, Abhay; Zheng, Yi; Fu, Jianping et al. (2017) Microfluidic-based high-throughput optical trapping of nanoparticles. Lab Chip 17:2125-2134
Zheng, Yi; Wang, Shue; Xue, Xufeng et al. (2017) Notch signaling in regulating angiogenesis in a 3D biomimetic environment. Lab Chip 17:1948-1959
Blatt, Neal B; Cornell, Timothy T (2017) The authors reply. Pediatr Crit Care Med 18:731
Yu, Zeta Tak For; Joseph, Jophin George; Liu, Shirley Xiaosu et al. (2017) Centrifugal microfluidics for sorting immune cells from whole blood. Sens Actuators B Chem 245:1050-1061
Yu, Zeta Tak For; Cheung, Mei Ki; Liu, Shirley Xiaosu et al. (2016) Accelerated Biofluid Filling in Complex Microfluidic Networks by Vacuum-Pressure Accelerated Movement (V-PAM). Small 12:4521-30
Hu, Shuhuan; Liu, Guangyu; Chen, Weiqiang et al. (2016) Multiparametric Biomechanical and Biochemical Phenotypic Profiling of Single Cancer Cells Using an Elasticity Microcytometer. Small 12:2300-11

Showing the most recent 10 out of 27 publications